Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:456-457
Published online before print February 9, 2009, doi: 10.1161/HYPERTENSIONAHA.108.125575
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
53/3/456    most recent
HYPERTENSIONAHA.108.125575v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlström, M.
Right arrow Articles by Persson, A. E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlström, M.
Right arrow Articles by Persson, A. E. G.
Related Collections
Right arrow Other hypertension
Right arrow Other Vascular biology

(Hypertension. 2009;53:456.)
© 2009 American Heart Association, Inc.


Editorial Commentaries

Important Role of NAD(P)H Oxidase 2 in the Regulation of the Tubuloglomerular Feedback

Mattias Carlström; A. Erik G. Persson

From the Department of Medical Cell Biology (M.C., A.E.G.P.), Division of Integrative Physiology, Uppsala University, Uppsala, Sweden; and the Department of Physiology and Pharmacology (M.C.), Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Correspondence to Mattias Carlström, Department of Medical Cell Biology, Uppsala University, S-751 23 Uppsala, Sweden. E-mail Mattias.Carlstrom@mcb.uu.se


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The tubuloglomerular feedback (TGF) mechanism is a negative feedback loop that senses changes in luminal NaCl delivery at the macula densa (MD) in the juxtaglomerular apparatus and adjusts the vascular tone of the afferent arteriole accordingly.1 This mechanism contribute importantly to the kidney’s ability to regulate renal microcirculation, fluid homeostasis, and, consequently, blood pressure. Adenosine appears to be the mediator of TGF,2 whereas angiotensin II, NO, and superoxide (O2) have important roles in modulating the response. A decrease in NO in the juxtaglomerular apparatus is associated with increased TGF sensitivity and an increase in arterial blood pressure.

Oxidative stress results from a shift in balance between the production of reactive oxygen species and action of antioxidant systems, in favor of reactive oxygen species, and has been implicated in the pathogenesis of hypertension.3 O2 is one of the main reactive oxygen species and is in the kidney predominantly formed by NADPH oxidases (NOXs) in the vasculature, cortex, and medulla. MD cells express the main units of NOX and produce O2 in response to angiotensin II or increased NaCl load. O2 has been shown to enhance the TGF response primarily by scavenging NO in the MD but also directly by constricting the afferent arteriole.4

Five NOX isoforms (NOX1 to 5) with a distinct tissue distribution have been found, and the potential isoforms expressed in the kidney are NOX1, NOX2, and NOX4. Using isolated and perfused afferent arterioles from NOX2-deficient mice, it was demonstrated recently that NOX2 (also known as gp91phox) plays . . . [Full Text of this Article]